financetom
Business
financetom
/
Business
/
National Bank Recaps Canadian Banks Q2
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
National Bank Recaps Canadian Banks Q2
Jun 3, 2024 10:55 AM

01:17 PM EDT, 06/03/2024 (MT Newswires) -- National Bank notes that overall , second quarter results of the Big 6 banks were good.

The main points were that five out the Big-6 banks beat consensus expectations; operating leverage was positive across the board; capital ratios continue to strengthen; and the outlook for certain business lines, such as Capital Markets, is positive.

"Ironically, considering economic divergence between Canada and the U.S., banks with greater exposure to the domestic market have outperformed," analyst Gabriel Dechaine writes and he expects that trend to continue.

BMO's U.S. credit performance, BNS' retreat from LatAm and TD's U.S. regulatory woes highlight some of the challenges outside of Canada, he notes. Furthermore, earlier rate cuts in Canada could serve to improve the growth outlook while also deflating credit cycle concerns (at least partially). This positioning favours CIBC and RBC (especially with HSBC CA) over BMO and TD.

"While we upgraded BMO last December, we believe the stock's upside potential will be deferred as a "higher for longer" rates in the U.S. weigh on the bank's credit outlook as well as its loan growth performance."

Price: 120.46, Change: -1.09, Percent Change: -0.90

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Biopharma firm Cingulate's Q3 net loss widens, misses analyst expectations
Biopharma firm Cingulate's Q3 net loss widens, misses analyst expectations
Nov 13, 2025
Overview * Cingulate ( CING ) Q3 net loss of $7.3 mln missed analyst expectations * R&D expenses rose 99.5% due to NDA submission costs for CTx-1301 * FDA accepted NDA for CTx-1301 with PDUFA date of May 2026 Outlook * Company anticipates needing $7 mln additional capital before May 2026 PDUFA date * Cingulate ( CING ) plans potential...
MediPharm Labs Q3 revenue up 17% on medical cannabis demand
MediPharm Labs Q3 revenue up 17% on medical cannabis demand
Nov 13, 2025
Overview * MediPharm Labs Q3 2025 revenue grows 17% yr/yr * Operating expenses decreased 19% yr/yr, contributing to increased cash balance Outlook * MediPharm ( MEDIF ) plans to launch inhalers in international markets, including the UK * Company focuses on international medical cannabis market expansion * MediPharm ( MEDIF ) aims to enhance profitability by streamlining expenses Result Drivers...
Redwire's Edge Autonomy Collaborates With Eurolink Systems to Promote Aerial Drones in Italy
Redwire's Edge Autonomy Collaborates With Eurolink Systems to Promote Aerial Drones in Italy
Nov 13, 2025
08:09 AM EST, 11/13/2025 (MT Newswires) -- Redwire ( RDW ) said Thursday that its Edge Autonomy subsidiary has teamed up with Eurolink Systems to bring unmanned military aircraft system technology to Italy. Financial terms were not disclosed. The partnership includes promotion and technical support of Edge Autonomy's drone portfolio in Italy, the company said. ...
Biomaterials firm SINTX misses Q3 revenue estimates
Biomaterials firm SINTX misses Q3 revenue estimates
Nov 13, 2025
Overview * SINTX ( SINT ) Q3 revenue of $0.2 mln missed analyst expectations * Operating expenses decreased 51% yr/yr, reducing operating loss to $3.4 mln * Company strengthened liquidity with $4.3 mln raised through warrant exercises Outlook * SINTX ( SINT ) plans to launch the SINAPTIC wedge system in the near term * Company aims to expand clinical...
Copyright 2023-2026 - www.financetom.com All Rights Reserved